Skip to main content

Appraisals - ASAR & FAR

01/08/2019
Appraisal Report: cetuximab (Erbitux) 2407
10/02/2020
Appraisal Report: certolizumab pegol (Cimzia) 1713
10/02/2020
Appraisal Report: certolizumab pegol (Cimzia) 1211
08/08/2019
Appraisal Report: ceftaroline fosamil (Zinforo) 1065
10/02/2020
Appraisal Report: cefepime (Renapime )4129
19/08/2019
Appraisal Report: capsaicin patch (Qutenza) 823
22/08/2019
Appraisal Report: capecitabine (Xeloda) 412
10/02/2020
Appraisal Report: cabozantinib (Cometriq) 577
08/08/2019
Appraisal Report: C1-esterase inhibitor (Berinert) 1425
23/10/2019
Appraisal Report: buprenorphine (Buvidal) 3977
07/08/2019
Appraisal Report: bupivacaine hydrochloride and fentanyl (Bufyl) 1578
31/07/2019
Appraisal Report: brimonidine (Mirvaso) 2168
10/02/2020
Appraisal Report: brentuximab vedotin (Adcetris) 1255
02/08/2019
Appraisal Report: botulinum toxin type A (Botox) 1429
01/08/2019
Appraisal Report: bortezomib (Velcade) 1807
09/08/2019
Appraisal Report: bortezomib (Velcade) 1254
31/07/2019
Appraisal Report: blinatumomab (Blincyto) 589
26/06/2019
Appraisal Report: bictegravir / emtricitabine / tenofovir alafenamide (Biktarvy®)
31/07/2019
Appraisal Report: beclometasone formoterol (Fostair) 2364
08/08/2019
Appraisal Report: aztreonam lysine (Cayston) 1715
Follow AWTTC: